The Medicines Company to Participate in J.P. Morgan 34th Annual Healthcare Conference

4 Jan 2016

PARSIPPANY, N.J.--(BUSINESS WIRE)--Jan. 4, 2016-- The Medicines Company (NASDAQ:MDCO) is scheduled to present at the J.P. Morgan 34th Annual Healthcare Conference in San Francisco, CA on Monday, January 11th at 7:30 AM PST / 10:30 AM EST.

The session will be webcast with a link available at The Medicines Company’s website

About The Medicines Company

The Medicines Company's purpose is to save lives, alleviate suffering and contribute to the economics of healthcare by focusing on 3000 leading acute/intensive care hospitals worldwide. Its vision is to be a leading provider of solutions in three areas: serious infectious disease care, acute cardiovascular care and surgery and perioperative care. The company operates in the Americas, Europe and the Middle East, and Asia Pacific regions with global centers today in Parsippany, NJ, USA and Zurich, Switzerland.

Source: The Medicines Company

The Medicines Company
Bob Laverty, +1-973-290-6162
Mobile: +1-609-558-5570
Vice President, Communications
Investor Relations:
Krishna Gorti, MD, +1-973-290-6122
Vice President, Investor Relations